Concepedia

Publication | Open Access

MiR-106a is an independent prognostic marker in patients with glioblastoma

DOIFull Paper Access

38

Citations

37

References

2013

Year

Shiguang Zhao, Guang Yang, Yulong Mu, Dayong Han, Shi Chen, Xin Chen, Yifan Deng, Daming Zhang, Lu Wang, Yaohua Liu,
Neuro-Oncology

Abstract

MiR-106a expression was relatively abundant and stable in a large cohort of archival FFPE GBM specimens and could be used as an independent prognostic biomarker in those patients. Thus, miR-106a can be used to predict prognosis and treatment response in individual GBM patients.

References

YearCitations

Page 1